We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Fan Zhang, PhD, of the University of Colorado Department of Medicine sees artificial intelligence as a pathway to combating an intractable enemy: rheumatoid arthritis.

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behavior or ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

It is not clear what would become of the federal government’s health care enforcement efforts without the False Claims Act’s qui tam program.

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

GlaxoSmithKline has initiated a £2bn share buyback programme starting today (24 Feb) with an initial tranche of up to £0.7bn. This starting amount will be used on treasury shares, none of which have ...

On the NSE, it was listed at Rs 576, down 8.42 per cent. Shares of GlaxoSmithKline Pharmaceuticals surged nearly 16% on Monday after the company reported a five-fold jump in net profit to Rs 229 ...

GlaxoSmithKline Pharmaceuticals shares hit 20 per cent upper circuit in trade on BSE at Rs 2,421.3 per share. The buying on the counter came after the company posted its Q3 results. Around 9:52 AM, ...

India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday ...